Skip to main content

D. E. Shaw & Co., Inc.

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1009207 New York, NY

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,901,497
+$589,890 QoQ
Shares Held
1,408,456
-10.5% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. AUPH ranks #43 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,901,497 1,408,456
2026-03-31 $23,311,607 1,572,983
2025-12-31 $24,439,753 1,532,273
2025-09-30 $10,054,637 909,922
2025-06-30 $2,892,843 341,540
2025-03-31 $2,125,960 264,423
2024-12-31 $1,197,330 133,333
2024-09-30 $688,645 93,949
2024-06-30 $490,453 85,894
2024-03-31 $409,527 81,742
2023-12-31 $832,132 92,562
2023-09-30 $2,775,023 357,146
2023-06-30 $5,938,804 613,513
2023-03-31 $5,537,583 505,254
2022-12-31 $459,146 106,284
2022-09-30 $750,774 99,837
2022-06-30 $1,141,278 113,560
2022-03-31 $976,942 78,913
2021-12-31 $4,307,175 188,333
2021-09-30 $7,388,520 333,869
2021-06-30 $513,358 39,611
2021-03-31 $153,677 11,835
2020-12-31 $4,163,286 301,033
2020-09-30 $4,994,044 339,039
2020-06-30 $1,900,697 116,966
2020-03-31 $1,779,476 122,638